The scale of insider selling by two top holders signals a planned exit, likely a secondary offering. Monitor for any lockup expirations or additional filings. The positive earnings may provide a floor, but the overhang is severe. Consider short-term bearish bias.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 18 $15.35entry
- T+1 · 6mo ago −0.78%α −0.13% · $15.23
- T+5 · 6mo ago +3.97%α +2.36% · $15.96
- T+20 · 5mo ago +4.50%α +2.91% · $16.04
- T+60 · 3mo ago +23.06%α +18.21% · $18.89
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two major sponsors (Warburg Pincus and GTCR) sold a combined ~31.8M shares worth approximately $482.9M in open-market transactions on May 13, representing about 11% of Sotera Health's market cap. This massive secondary selling creates significant overhang despite the company's solid Q1 earnings and reaffirmed guidance.
Key Financial Metrics
Key Facts
- Warburg Pincus sold 19.1M shares at $15.17, totaling $289.8M.
- GTCR Investment XI sold 12.7M shares at $15.17, totaling $193.2M.
- Total insider sales of $482.9M represent ~11% of SHC's $4.4B market cap.
- Sales occurred 8 days after Q1 earnings (May 5) which showed 10% revenue growth and a return to profitability.
Financial Impact
Approximately 11% of market cap sold in open-market transactions, creating substantial supply overhang.
Risk Factors
- Additional selling by remaining sponsors or insiders.
- Stock price pressure from the large block trades.
- Potential for further dilution if secondary offering follows.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SHC-1778878166403 |
Track record
18 reports on SHC
5 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +16.44% at T+60 after the May 5, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 3, 202613d ago 8-K Neutral 5/10 No price data
- Nov 3, 202613d ago Press Release Bullish 5/10 Entry $16.03 to $16.39 Now $16.25 +1.37% ▲ +2.25% +0.59% vs SPY
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $18.15 to $17.74 Now $16.25 −10.47% ▼ −2.26% −1.78% vs SPY
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $18.13 to $18.10 Now $16.25 −10.37% ▼ −0.17% +0.36% vs SPY
- Oct 9, 20265w ago SC 13G/A Bearish 5/10 Entry $18.15 to $18.21 Now $16.25 +10.47% ▼ −0.33% −0.34% vs SPY
- Aug 14, 202613w ago 8-K Neutral 2/10 Entry $18.89 to $18.80 Now $16.25 −13.98% ▼ −0.48% −0.00% vs SPY
- Aug 9, 202614w ago Institutional Cluster Bullish 4/10 Entry $18.97 to $19.11 Now $16.25 −14.34% ▲ +0.74% +1.06% vs SPY
- Aug 7, 202614w ago 144 Neutral 3/10 Entry $18.86 to $18.97 Now $16.25 −13.84% ▲ +0.58% +0.61% vs SPY
- Aug 6, 202614w ago 8-K Bullish 7/10 Entry $18.91 to $18.86 Now $16.25 −14.07% ▼ −0.26% −0.88% vs SPY
- May 27, 202624w ago 3 Neutral 2/10 Entry $15.75 to $15.64 Now $16.25 +3.17% ▼ −0.70% −0.94% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers